186 results
Page 2 of 10
8-K
EX-99.1
o2eesi3td 1bt6awu8je
24 Apr 23
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors
8:13am
8-K
EX-10.1
izrx7sdrlvq
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
8-K
EX-99.1
70nuajxy fs0aq5q1r
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
8-K
e4o23 ii6oscljs
4 Apr 23
Other Events
8:30am
8-K
EX-99.1
ow32m tnes3k
26 Oct 22
Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
8:00am
8-K
EX-99.1
00f7p1hbtg06sl4n3rs
15 Aug 22
Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
8:00am
8-K
EX-99.1
45pd2p2exgdh tt
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
8-K
EX-99.1
fiex0ucsw2
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
8-K
EX-99.1
giwjjsbp3
22 Dec 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
7fbfis6bwz8n8rgk2
15 Nov 21
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development
8:00am
8-K
EX-1.1
eht 591ftp3gwo
5 May 21
Entry into a Material Definitive Agreement
5:02pm
424B5
0uwlxs2lcstxcc
5 May 21
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
9iqjyx3l
5 May 21
Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock
7:52am